Cansino Biologics Inc (688185) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.45x

Cansino Biologics Inc (688185) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting CN¥44.23 Million (capex CN¥44.23 Million ) from operating cash flow of CN¥30.53 Million. Check Cansino Biologics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.45x

(Capex + Investments) / Operating CF

Total Reinvested

CN¥44.23 Million

Capex + Investments

Operating Cash Flow

CN¥30.53 Million

CNY

Capital Expenditures

CN¥44.23 Million

CNY

Cansino Biologics Inc Cash Flow Reinvestment Rate (2021–2025)

Historical reinvestment intensity for Cansino Biologics Inc across 2 annual periods. Explore Cansino Biologics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Cansino Biologics Inc (2021–2025)

Year-by-year capital reinvestment analysis for Cansino Biologics Inc. For live market cap and broader valuation context, see 688185 company net worth.

Year	Reinvestment Rate	Total Reinvested (CNY)	Operating CF	Capex	YoY Change
2025	10.78x	CN¥839.60 Million	CN¥77.86 Million	CN¥243.90 Million	▲ +733.6%
2021	1.29x	CN¥2.61 Billion	CN¥2.01 Billion	CN¥1.20 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow